Zhejiang Garden Biopharmaceutical Co.,Ltd. (SHE:300401)

Market Cap	7.99B
Revenue (ttm)	1.24B
Net Income (ttm)	314.24M
Shares Out	543.47M
EPS (ttm)	0.55
PE Ratio	26.97
Forward PE	17.20
Dividend	0.11 (0.77%)
Ex-Dividend Date	Apr 30, 2025

Volume	15,600,700
Average Volume	22,585,435
Open	14.83
Previous Close	14.82
Day's Range	14.66 - 15.02
52-Week Range	10.88 - 18.46
Beta	0.58
RSI	44.31
Earnings Date	Aug 22, 2025

About SHE:300401

Zhejiang Garden Biopharmaceutical Co.,Ltd. manufactures and supplies lanolin cholesterol, vitamin D3, 25-hydroxyvitamin D3, and refined lanolin products in China. It offers cholesterol; feed grade cholesterol; food additives compound nutrient fortifier SDS, CO, and MO; cholecalciferol; feed additive - vitamin D3 particles and oil; VD3 resin oil; 25 hydroxyvitamin D3 progen and powder; 25 hydroxyvitamin D3; anhydrous lanolin; wood oil; wool wax; low chroma pure fat; lanolin alcohol; isopropyl lanolate; lanolinic acid; high acid fat; wood acid bi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2000
• Employees: 1,021
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300401

Financial Performance

In 2024, SHE:300401's revenue was 1.24 billion, an increase of 13.58% compared to the previous year's 1.09 billion. Earnings were 309.21 million, an increase of 60.76%.